mara rada
@mararada.bsky.social
prevention maximalist
AI / drug reimbursement / market access / health economics / outcomes research
AI / drug reimbursement / market access / health economics / outcomes research
Vaccines are good for you and protect you against a debilitating disease.
One of the best ways you can reduce your risk of getting Long COVID is to get vaccinated.
Vaccines Slash Long COVID Risk
According to a new study.
time.com
November 25, 2023 at 10:44 PM
Vaccines are good for you and protect you against a debilitating disease.
Reposted by mara rada
I've studied AI extensively, I dislike using the term. Too much noise obscuring AI true purpose. In medicine, AI is a tool that needs standard measures for diagnosis & therapy (e.g. positive and negative predictive value). Treating AI as a mere tool, not an alien concept, will expedite its adoption.
Ghayath Janoudi on LinkedIn: An AI revolution is brewing in medicine. What will it look like?
If you know me, you know I don't really like to say the words Artificial Intelligence or AI. But do you know why?
It’s not because I don't think this is an…
www.linkedin.com
October 25, 2023 at 8:28 PM
I've studied AI extensively, I dislike using the term. Too much noise obscuring AI true purpose. In medicine, AI is a tool that needs standard measures for diagnosis & therapy (e.g. positive and negative predictive value). Treating AI as a mere tool, not an alien concept, will expedite its adoption.
Would you take your car to a shop that fixes 1 out of ten cars?
No?
Then why are we ok with clinical
trials success rate of 10%?
#BiotechIsBroken
No?
Then why are we ok with clinical
trials success rate of 10%?
#BiotechIsBroken
In car shops, fixing 1 car out of 10 is unacceptable. So why do we accept a 90% failure rate in clinical trials?
Because we focus on patents, not patients. To enhance success rates, we must normalize and streamline clinical discovery, evidence synthesis, and generation. Prioritize patients, not IP!
Because we focus on patents, not patients. To enhance success rates, we must normalize and streamline clinical discovery, evidence synthesis, and generation. Prioritize patients, not IP!
Ghayath Janoudi on LinkedIn: What’s the parallel between car shops and drug development?
“This ...
What’s the parallel between car shops and drug development?
“This car shop is fantastic! Out of every 10 cars they see, they're able to fix 1.” said no one…
www.linkedin.com
October 25, 2023 at 3:20 AM
Would you take your car to a shop that fixes 1 out of ten cars?
No?
Then why are we ok with clinical
trials success rate of 10%?
#BiotechIsBroken
No?
Then why are we ok with clinical
trials success rate of 10%?
#BiotechIsBroken